Adjuvant intra-arterial lipiodol-iodine-131 for resectable hepatocellular carcinoma: a prospective randomised trial
Lau Wy(Chinese University of Hong Kong), PJ Johnson(Chinese University of Hong Kong), Michael Chan(Chinese University of Hong Kong), Joseph T. F. Lau(Chinese University of Hong Kong), David Machin(National Medical Research Council), SKW Ho(Chinese University of Hong Kong), NWY Leung(Chinese University of Hong Kong), ATC Chan(Chinese University of Hong Kong), Winnie Yeo(Chinese University of Hong Kong), TWT Leung(Chinese University of Hong Kong), Simon C.H. Yu(National Yang Ming Chiao Tung University)
Cited by 408
Related Papers
National Kidney Foundation Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification
|Annals of Internal Medicine|2003|4.6k
Quantitative Synthesis in Systematic Reviews
|Annals of Internal Medicine|1997|2.5k
Efficacy and safety of incretin therapy in type 2 diabetes: systematic review and meta-analysis.
|PubMed|2007|1.1k